project id: TCGA-CESC; case submitter id: TCGA-R2-A69V; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.38; rna integrity number: 7.3; age at index: 42; days to birth: -15479; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1969; age at diagnosis: 15479; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic t: T1b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 596.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 548; initial weight: 780.0; oct embedded: false; preservation method: Unknown; sample id: a48d2173-fe97-4fea-8f4e-ba81b5f6a833; sample submitter id: TCGA-R2-A69V-01A; portion id: 0c9552fe-4846-4e47-90a7-dc1b12b3f2a9; portion submitter id: TCGA-R2-A69V-01A-11; slide id: 4e119910-a26e-49e4-b32a-2f415f7c1d4c; slide submitter id: TCGA-R2-A69V-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; section location: TOP;